Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
8.58
-0.02 (-0.23%)
Dec 27, 2024, 4:00 PM EST - Market closed
Company Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.
It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Inogen, Inc.
| Country | United States |
| Founded | 2001 |
| IPO Date | Feb 14, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 834 |
| CEO | Kevin R. Smith |
Contact Details
Address: 859 Ward Drive Goleta, California 93111 United States | |
| Phone | 805 562 0500 |
| Website | inogen.com |
Stock Details
| Ticker Symbol | INGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001294133 |
| CUSIP Number | 45780L104 |
| ISIN Number | US45780L1044 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. M. Smith | President, Chief Executive Officer and Director |
| Michael J. Bourque CPA | Executive Vice President, Chief Financial Officer and Treasurer |
| Philip Corrin | Senior Vice President of Operations and Supply Chain |
| Kevin P. Smith | General Counsel and Executive Vice President of Business Development |
| Jennifer Yi Boyer | Executive Vice President and Chief Human Resources Officer |
| Grgoire Ramade | Executive Vice President and Chief Commercial Officer |
| Dr. Krishna Jhaveri | Chief Medical Officer |
| Paul Andreassi | Senior Vice President of Quality and Regulatory Affairs |
| Adrien Mithalal | Senior Vice President of Research and Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | 10-Q | Quarterly Report |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 8-K | Current Report |
| Oct 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 9, 2024 | 144 | Filing |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Jul 31, 2024 | 8-K | Current Report |
| Jul 3, 2024 | 8-K | Current Report |